4 news items
TriLink BioTechnologies collaborates with Johns Hopkins University to establish a new RNA Innovation Center
MRVI
13 May 24
and custom materials, including its patented CleanCap® mRNA capping technology. Pharmaceutical leaders, biotech disruptors, and world governments
TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance Production
MRVI
18 Apr 24
experience, CDMO services, and high-quality readymade and custom materials, including its patented CleanCap® mRNA capping technology
Market Momentum: NASDAQ SmallCaps Sparking Waves in March 2024: CELZ, DYAI, GROM, VTAK, BREA
BREA
CELZ
DIS
8 Mar 24
materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee
Recent Market Movers: Healthcare Companies Making Headlines: DYAI, RIGL, ARDX, VERO, MEDS
ARDX
DYAI
MEDS
28 Feb 24
at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from
- Prev
- 1
- Next